Aytu BioPharma (AYTU) Scheduled to Post Earnings on Wednesday

Aytu BioPharma (NASDAQ:AYTU) is set to release its earnings data after the market closes on Wednesday, November 13th.

Aytu BioPharma (NASDAQ:AYTU) last released its quarterly earnings results on Thursday, September 26th. The company reported ($0.82) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.45) by ($0.37). The firm had revenue of $17.98 million for the quarter. Aytu BioPharma had a negative return on equity of 51.31% and a negative net margin of 19.56%.

Aytu BioPharma Stock Up 7.9 %

Shares of Aytu BioPharma stock opened at $1.77 on Tuesday. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.79 and a current ratio of 0.99. Aytu BioPharma has a 1-year low of $1.60 and a 1-year high of $3.45. The business has a 50-day moving average of $2.28 and a 200-day moving average of $2.64.

Aytu BioPharma Company Profile

Aytu Biopharma, Inc, a commercial-stage pharmaceutical company, focuses on commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company operates through two segments: Rx segment and Consumer Health segment. The Rx segment offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT for patients from six years and older, and Cotempla XR-ODT for patients from six to seventeen years old.